Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2021 Filed Jul 29, 2021 21:01 UTC |
Sela YossiDirector · Former 10% Owner
|
ConversionSeries A Preferred Stock · Derivative | 1,667,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-097647 · tm2123665-5_4seq1.xml · derivative · entry 2 Sela Yossi · CIK 0001402094 · Director · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,667,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_price: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.exercise_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · derivative.expiration_date: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1 · ownership.nature: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2 · ownership.nature: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 21:01 UTC |
Sela YossiDirector · Former 10% Owner
|
ConversionCommon Stock | 4,383,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-097647 · tm2123665-5_4seq1.xml · nonDerivative · entry 1 Sela Yossi · CIK 0001402094 · Director · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,921,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F3 · balance_after: The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. F1 · ownership.nature: The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds. F2 · ownership.nature: The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2021 Filed Apr 13, 2022 20:32 UTC Amendment |
Wolter ArneDirector
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-005208 · marketforms-55989.xml · nonDerivative · entry 1 Wolter Arne · CIK 0001874533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · security: This Form 4 amendment is being filed to correct the original Form 4 filed on July 29, 2021. The shares of common stock listed in Table I have been updated to include total restricted stock units held by the reporting person, previously reported in Table II. F2 · shares: These restricted stock units will vest over a period of three (3) years on a quarterly basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.